HUTCHMED (China) (HUTCHMED (China)) Additional Paid-In Capital : $1,522.4 Mil(As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Additional Paid-In Capital?

HUTCHMED (China)'s quarterly additional paid-in capital increased from Dec. 2022 ($1,497.3 Mil) to Jun. 2023 ($1,506.3 Mil) and increased from Jun. 2023 ($1,506.3 Mil) to Dec. 2023 ($1,522.4 Mil).

HUTCHMED (China)'s annual additional paid-in capital declined from Dec. 2021 ($1,505.2 Mil) to Dec. 2022 ($1,497.3 Mil) but then increased from Dec. 2022 ($1,497.3 Mil) to Dec. 2023 ($1,522.4 Mil).

HUTCHMED (China) Additional Paid-In Capital Historical Data

The historical data trend for HUTCHMED (China)'s Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Additional Paid-In Capital Chart

HUTCHMED (China) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

514.90

822.46

1,505.20

1,497.27

1,522.45

HUTCHMED (China) Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															1,505.20	1,484.58	1,497.27	1,506.28	1,522.45

HUTCHMED (China) Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

HUTCHMED (China) Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

HUTCHMED (China) (HUTCHMED (China)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (NAS:HCM) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

00013:Hong Kong HCM.GB:UK HCM:UK H7T2:Germany

Address

2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG

Website

https://www.hutch-med.com

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.